News

The project being funded by IAVI’s Innovation Fund will integrate the specialized design capabilities of GMI, the novel biomolecular simulation technology of G&D with the vaccine design expertise

Under the terms of the agreement, Hanmi acquired regional marketing rights for Korea and China and will make an upfront payment, development and sales milestones, and royalties on

As measured by the Montgomery-Asberg Depression Rating Scale, the bipolar I depression patients treated with Latuda experienced statistically significant improvements in symptoms of depression compared to patients taking

The grant will support R&D expenses for the 12-month period from October 2011 through September 2012 to advance research of the Biopump platform technology in a number of

The study will be conducted in 124 patients with CTCL, including those with primary cutaneous anaplastic large cell lymphoma (pcALCL) or mycosis fungoides (MF). The overall response rate,

Xarelto is presently under review with the FDA to reduce the risk of secondary cardiovascular events in patients with ACS. The filing is supported by data from the

As per the agreement, GeneSeek gained certain non-exclusive rights to a number of GTG patents relating to its non-coding DNA technology. The other terms of the agreement have

The recommendation will be considered by the FDA in its review of the new drug application for tofacitinib. Pfizer Specialty Care Medicines Development Group head and senior vice

Evotec’s high content screening combined with 4-Antibody’s antibody selection approach will offer new possibilities for reduced late stage attrition and better efficacy. The high content screening approach will